WG Biotech ApS
SEC insider (Form 3/4/5 filer). CIK 0001753193. Director & 10% Owner at Y-mAbs Therapeutics, Inc. (YMAB). 1 reported Form 4/5 transaction since Sep 2024; latest on Sep 16, 2025. Located in RUNGSTED KYST, G7.
Companies WG Biotech ApS has filed insider reports for
- Y-mAbs Therapeutics, Inc. (YMAB): Director, 10% Owner
WG Biotech ApS
CIK: 0001753193
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (100.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
YMAB
Y-mAbs Therapeutics, Inc.
Director10% Owner